10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
85.71
+1.60 (1.90%)
At close: Sep 25, 2026, 4:00 PM EDT
85.50
-0.21 (-0.25%)
After-hours: Sep 25, 2026, 7:59 PM EDT
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $11.17 billion as of September 25, 2026. Its market cap has increased by 643.81% in one year.
Market Cap
11.17B
Enterprise Value
10.69B
1-Year Change
643.81%
Ranking
Category
Stock Price
$85.71
ChartMarket Cap Chart
Since September 12, 2019, 10x Genomics's market cap has increased from $4.95B to $11.17B, an increase of 125.58%. That is a compound annual growth rate of 12.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 11.17B | 441.03% |
| Dec 31, 2025 | 2.06B | 18.74% |
| Dec 31, 2024 | 1.74B | -73.72% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Koninklijke Philips | 23.85B |
| STERIS | 20.37B |
| Zimmer Biomet Holdings | 17.36B |
| Penumbra | 12.56B |
| Smith & Nephew | 11.23B |
| Bio-Rad Laboratories | 10.25B |
| Bio-Rad Laboratories | 10.19B |
| Globus Medical | 10.01B |